123 related articles for article (PubMed ID: 23824994)
21. Graphical methods for detecting bias in meta-analysis.
Ferrer RL
Fam Med; 1998 Sep; 30(8):579-83. PubMed ID: 9773289
[TBL] [Abstract][Full Text] [Related]
22. Review of randomized controlled trials: issues to consider when designing a trial.
Pandis N
Am J Orthod Dentofacial Orthop; 2013 Jun; 143(6):905-7. PubMed ID: 23726342
[No Abstract] [Full Text] [Related]
23. Randomised trials with provision for early stopping for benefit (or harm): The impact on the estimated treatment effect.
Walter SD; Guyatt GH; Bassler D; Briel M; Ramsay T; Han HD
Stat Med; 2019 Jun; 38(14):2524-2543. PubMed ID: 30887553
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis and meta-analytic monitoring of clinical trials.
Feinstein AR
Stat Med; 1996 Jun; 15(12):1273-80; discussion 1281-3. PubMed ID: 8817801
[TBL] [Abstract][Full Text] [Related]
25. Problems caused by heterogeneity in meta-analysis: a case study of acupuncture trials.
Prady SL; Burch J; Crouch S; MacPherson H
Acupunct Med; 2014 Feb; 32(1):56-61. PubMed ID: 24140758
[TBL] [Abstract][Full Text] [Related]
26. A systematic survey of randomised trials that stopped early for reasons of futility.
Walter SD; Han H; Guyatt GH; Bassler D; Bhatnagar N; Gloy V; Schandelmaier S; Briel M
BMC Med Res Methodol; 2020 Jan; 20(1):10. PubMed ID: 31948397
[TBL] [Abstract][Full Text] [Related]
27. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
Wang Y; Berlin JA; Pinheiro J; Wilcox MA
Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity analyses assessing the impact of early stopping on systematic reviews: Recommendations for interpreting guidelines.
Marschner IC; Askie LM; Schou IM
Res Synth Methods; 2020 Mar; 11(2):287-300. PubMed ID: 31901013
[TBL] [Abstract][Full Text] [Related]
29. Assessment of risk of bias in randomized clinical trials in surgery.
Gurusamy KS; Gluud C; Nikolova D; Davidson BR
Br J Surg; 2009 Apr; 96(4):342-9. PubMed ID: 19283747
[TBL] [Abstract][Full Text] [Related]
30. An evaluation of bioactive glass in the treatment of periodontal defects: a meta-analysis of randomized controlled clinical trials.
Sohrabi K; Saraiya V; Laage TA; Harris M; Blieden M; Karimbux N
J Periodontol; 2012 Apr; 83(4):453-64. PubMed ID: 21861641
[TBL] [Abstract][Full Text] [Related]
31. Statistical issues in interpreting clinical trials.
DeMets DL
J Intern Med; 2004 May; 255(5):529-37. PubMed ID: 15078496
[TBL] [Abstract][Full Text] [Related]
32. The impact of stopping rules on heterogeneity of results in overviews of clinical trials.
Hughes MD; Freedman LS; Pocock SJ
Biometrics; 1992 Mar; 48(1):41-53. PubMed ID: 1581492
[TBL] [Abstract][Full Text] [Related]
33. Blinded sample size re-estimation in superiority and noninferiority trials: bias versus variance in variance estimation.
Friede T; Kieser M
Pharm Stat; 2013; 12(3):141-6. PubMed ID: 23509095
[TBL] [Abstract][Full Text] [Related]
34. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles.
Shrier I; Boivin JF; Steele RJ; Platt RW; Furlan A; Kakuma R; Brophy J; Rossignol M
Am J Epidemiol; 2007 Nov; 166(10):1203-9. PubMed ID: 17712019
[TBL] [Abstract][Full Text] [Related]
35. Are current standards of reporting quality for clinical trials sufficient in addressing important sources of bias?
Mills EJ; Ayers D; Chou R; Thorlund K
Contemp Clin Trials; 2015 Nov; 45(Pt A):2-7. PubMed ID: 26232560
[TBL] [Abstract][Full Text] [Related]
36. Stopping rules and estimation problems in clinical trials.
Hughes MD; Pocock SJ
Stat Med; 1988 Dec; 7(12):1231-42. PubMed ID: 3231947
[TBL] [Abstract][Full Text] [Related]
37. Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data.
Shimura M; Gosho M; Hirakawa A
Stat Med; 2017 Jun; 36(13):2067-2080. PubMed ID: 28211076
[TBL] [Abstract][Full Text] [Related]
38. A note regarding meta-analysis of sequential trials with stopping for efficacy.
Senn S
Pharm Stat; 2014; 13(6):371-5. PubMed ID: 25296692
[TBL] [Abstract][Full Text] [Related]
39. Estimation of between-trial variance in sequential meta-analyses: a simulation study.
Novianti PW; Roes KC; van der Tweel I
Contemp Clin Trials; 2014 Jan; 37(1):129-38. PubMed ID: 24321246
[TBL] [Abstract][Full Text] [Related]
40. Standardized mean differences in individually-randomized and cluster-randomized trials, with applications to meta-analysis.
White IR; Thomas J
Clin Trials; 2005; 2(2):141-51. PubMed ID: 16279136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
